Research summary ·
Biomarkers of Lyme neuroborreliosis: a systematic review.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
Doctors still find Lyme neuroborreliosis (LNB) hard to diagnose. This study was a systematic review of past research. It looked at biomarkers, which are signs measured in blood or body fluid. The team searched several large research databases. Doctors with LNB skills chose which studies to include. They also rated the quality of each study with a set tool.
What they found
The search found 3113 studies, and 74 were included. These studies tested 220 different biomarkers. They covered 2598 people with LNB in 13 countries. The studies were done from 1990 to 2025. No blood test gave steady results across studies. In the fluid around the brain and spine (CSF), IL-10 ranked highest.
What it means for patients
The authors say much of this research repeats itself. Only a few biomarkers worked the same way across studies. They say future work should test the top biomarkers more carefully. This may help bring such tests into use with patients sooner. They also say we need to know more about how LNB develops.
Why it is not certain yet
IL-10 ranked highest, but it still needs further testing. The abstract does not give how well IL-10 performed. It also does not report the quality ratings of the studies. A review can only be as good as the studies in it.
Source
Biomarkers of Lyme neuroborreliosis: a systematic review.
PubMed · PMID 42545454We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Lyme disease publications